1. 804 A phase II study of the anti-programmed cell death-1 (PD-1) antibody penpulimab in patients with metastatic nasopharyngeal carcinoma (NPC) who had progressed after two or more lines of chemotherapy. (9th November 2020) Authors: Chen, Xiaozhong; Wang, Wei; Zou, Qingfeng; Li, Jingao; Hu, Chaosu; Hu, Chaosu; Lin, Qin; Zhu, Xiaodong; Jiang, Yi; Sun, Yan; Shen, Liangfang; Wang, Lin; Zou, Guorong; Lin, Xiaoyan; Wang, Ying; Lin, Shaojun; Li, Minying; Ao, Rui; Xu, Ruilian; Lin, Haifeng Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The impact of antibiotic selection and interval time among advanced non‐small cell lung cancer patients receiving prior antibacterial treatment and first‐line chemotherapy. (11th May 2022) Authors: Tian, Xiaoman; Mei, Ting; Yu, Min; Li, Yanying; Ao, Rui; Gong, Youling Journal: Cancer medicine Issue: Volume 11:Number 24(2022) Page Start: 4849 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗